Overcoming international problems, a large-scale study by Chinese scholars is the first to authoritatively define the scope of lymph node dissection for esophageal cancer

China News Online, August 11 (Chen Jing Wang Guangzhao) China is a country with a high incidence of esophageal cancer.

The reporter learned on the 11th that the large-scale research conducted by the team of Professor Chen Haiquan of Thoracic Surgery of Fudan University Cancer Hospital has taken the lead in clearly defining the scope of lymph node dissection for esophageal cancer in the international academic community

It is reported that the "two fields" include the middle and lower mediastinum, upper abdomen and the cervical-thoracic junction; "three fields" refers to "'two fields' + neck"

Clinical data shows that more than half of patients with esophageal cancer have lymph node metastasis at the time of treatment

It is understood that in the expert review that was invited for the official journal of the American Society of Thoracic Surgery, the Journal of Thoracic and Cardiovascular Surgery, the authoritative expert in the field of esophageal cancer treatment and Professor Nasser Altorki from New York Presbyterian Hospital highly praised Professor Chen Haiquan’s team for esophageal cancer.

The esophagus is the digestive organ that connects the pharynx and stomach

The large-scale clinical research conducted by the team led by Professor Chen Haiquan enrolled hundreds of patients in more than three years

The epidemiological data of esophageal cancer are different in eastern and western countries

Based on the cutting-edge data of previous countries and the research results of Professor Chen Haiquan’s team this time, Professor Altoiki believes that among Western patients with esophageal cancer and adenocarcinoma, the survival of patients with “three-field” and “two-field” lymph node dissection surgery is extremely good.